Search

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Experts suggest that outsourcing CGT manufacturing capabilities to CDMOs brings additional benefits, although not without challenges

Experts from Emergent BioSolutions break down the qualities that make an ideal CDMO partner for plasma- based protein manufacturing

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Is renting material handling equipment the best way to help manufacturers tackle waste?

What sustainability benefits can be gained from smart choices and reduced material use?

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

Transporting temperature-sensitive pharmaceuticals is only going to become more challenging as we face the realities of the climate crisis.

How to ensure your reaction to recalls is driven by data and knowledge.

The Greek philosopher Heraclitus would have (most likely) agreed that QC and QA labs must be prepared for changes.